Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early postnatal hydrocortisone for prevention of bronchopulmonary dysplasia in extremely preterm infants
2007-002041-20Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Survival without bronchopulmonary dysplasia at 36 weeks of amenorrhea. Started Oct 2007; status: completed.
02
Drugs
hydrocortisone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on 2007-002041-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002041-20.